Investing.com - Novo Nordisk (NYSE:NVO) ADR reported on Wednesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Novo Nordisk ADR announced earnings per share of kr4.76 on revenue of kr38.33B. Analysts polled by Investing.com anticipated EPS of kr0.7152 on revenue of kr5.78B.
Novo Nordisk ADR shares are down 10% from the beginning of the year, still down 12.61% from its 52 week high of kr117.35 set on December 16, 2021. They are under-performing the S&P 500 which is down 4.61% from the start of the year.
Novo Nordisk ADR follows other major Healthcare sector earnings this month
Novo Nordisk ADR's report follows an earnings beat by J&J on January 25, who reported EPS of kr2.13 on revenue of kr24.8B, compared to forecasts EPS of kr2.12 on revenue of kr25.28B.
UnitedHealth had beat expectations on January 19 with fourth quarter EPS of kr4.48 on revenue of kr73.74B, compared to forecast for EPS of kr4.3 on revenue of kr72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar